Cost-Effectiveness Thresholds: Economic and ethical issues

Clive Pritchard;Nancy Devlin;Adrian Towse
Authors registered in the RePEc Author Service: Adrian Towse and Nancy Devlin ()

Monograph from Office of Health Economics

Abstract: The papers in this book are based on the proceedings of a workshop jointly organised by the OHE and the King’s Fund and hosted by the King’s Fund on 1 March 2002. The authors of the papers that make up this book were asked to address a specific question: ‘Ought NICE to have a threshold incremental cost-effectiveness ratio (ICER)?’ -with an implicit second question ‘Should the threshold be explicit?’ Since its inception, NICE (the National Institute for Clinical Excellence) has made a very firm and public commitment to maximise the openness and transparency of its criteria and the processes through which they are developed and applied. It therefore seems uncontroversial that any such threshold ought to be explicit

Keywords: Cost-Effectiveness; Thresholds:; Economic; and; ethical; issues (search for similar items in EconPapers)
JEL-codes: I1 (search for similar items in EconPapers)
Date: 2002-11-01
References: View complete reference list from CitEc
Citations: View citations in EconPapers (21)

Downloads: (external link)
https://www.ohe.org/publications/cost-effectivenes ... ss_thresholds_towse/ (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ohe:monogr:000473

Access Statistics for this paper

More papers in Monograph from Office of Health Economics Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).